The Role of Acupuncture-induced Exosome in Treating Post-stroke Dementia

C

China Medical University

Status

Enrolling

Conditions

Acupuncture
Exosome
Post-stroke Dementia

Treatments

Device: Acupuncture

Study type

Interventional

Funder types

Other

Identifiers

NCT05326724
CMUH111-REC2-024

Details and patient eligibility

About

Stroke is the main cause of disability and the second main cause of dementia. Approximately 21.5% of patients develop dementia within 4 years after stroke. The main clinical manifestation of dementia is memory and cognitive impairment. At present, acetylcholinesterase inhibitors and NMDA glutamate receptor antagonists, were used for dementia treatment, but those drugs have limited efficacy. Exosome is an extracellular vesicle from the endosomal, size range from \~40 to 160 nm (average \~100 nm). It contains many cells including DNA, RNA, fat, and metabolites, as well as cytoplasm and cell surface proteins that play a role in regulating intercellular communication. Some studies believe that exosomes in the circulation are an ideal marker to reflect the pathological progress and recovery of stroke, and play a key role in the reorganization of tissues and the progress of neurodegeneration after stroke. Our previous studies have known that acupuncture can increase the long-term potentiation of hippocampal CA1 in rats with ischemic stroke, and improve learning-memory and neurological function. Therefore, the purpose of this study is to explore the role of acupuncture-induced exosome in the treatment of post-stroke dementia.

Enrollment

30 estimated patients

Sex

All

Ages

50 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. History of stroke.
  2. MMSE score between 16 and 26.

Exclusion criteria

  1. Those with serious diseases, such as heart failure, chronic failure or cancer patients, etc.
  2. Intolerance to acupuncture treatment.
  3. Allergy to acupuncture needles.
  4. Refusal to sign the informed consent form.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Acupuncture
Experimental group
Treatment:
Device: Acupuncture

Trial contacts and locations

1

Loading...

Central trial contact

Ching-Liang Hsieh, Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems